Видео ютуба по тегу 게피티닙

비소세포폐암(NSCLC) 표적 항암치료제: EGFR TKIs(gefitinib, erlotinib) 원리(mechanism)
비소세포폐암(NSCLC) 표적 항암치료제: EGFR TKIs(gefitinib, erlotinib) 원리(mechanism)
Role of Gefitinib in EGRF-Mutant Disease
Role of Gefitinib in EGRF-Mutant Disease
전문약사가 설명하는 항암제 게피티니브(게피티닙)의 부작용과 예방법, 복용을 잊었을 때는?
전문약사가 설명하는 항암제 게피티니브(게피티닙)의 부작용과 예방법, 복용을 잊었을 때는?
Gefitinib Approved for NSCLC, Atezolizumab Shrinks Bladder Tumors, and More
Gefitinib Approved for NSCLC, Atezolizumab Shrinks Bladder Tumors, and More
Efficacy and Safety of Afatinib vs Erlotinib and Gefitinib in EGFR+ NSCLC
Efficacy and Safety of Afatinib vs Erlotinib and Gefitinib in EGFR+ NSCLC
Reconsideration of Gefitinib in EGFR-Mutant NSCLC
Reconsideration of Gefitinib in EGFR-Mutant NSCLC
Gefitinib: Targeted Treatment for EGFR Mutation-Positive Lung Cancer | GlpBio
Gefitinib: Targeted Treatment for EGFR Mutation-Positive Lung Cancer | GlpBio
How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC
How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC
Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer
Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer
Elderly Patients with EGFR-Mutated Lung Cancer: Afatinib, Gefitinib, Erlotinib Study | Aging-US
Elderly Patients with EGFR-Mutated Lung Cancer: Afatinib, Gefitinib, Erlotinib Study | Aging-US
Gefitinib with Chemotherapy does not Significantly Improve Progression-Free Survival Lung Cancer
Gefitinib with Chemotherapy does not Significantly Improve Progression-Free Survival Lung Cancer
Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemotherapy
Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemotherapy
Dr. Drilon on Tepotinib and Gefitinib in MET+ EGFR-Mutant NSCLC
Dr. Drilon on Tepotinib and Gefitinib in MET+ EGFR-Mutant NSCLC
Dr. West on the Gefitinib Advanced NSCLC Trial
Dr. West on the Gefitinib Advanced NSCLC Trial
【EGFR inhibitors】Cetuximab (ERBITUX®) , Panitumumab, Erlotinib , Gefitinib (Iressa®), Afatinib
【EGFR inhibitors】Cetuximab (ERBITUX®) , Panitumumab, Erlotinib , Gefitinib (Iressa®), Afatinib
에이치엘비 리보세라닙 병용에서 우수한 PFS가 나온 gefitinib은 무슨 약인가?
에이치엘비 리보세라닙 병용에서 우수한 PFS가 나온 gefitinib은 무슨 약인가?
Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors
Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors
[표적항암제] 비소세포폐암 표적항암제 '지오트립' 효과와 부작용 완벽 정리
[표적항암제] 비소세포폐암 표적항암제 '지오트립' 효과와 부작용 완벽 정리
LUX-Lung 7: Phase 2b trial of afatinib versus gefitinib for EGFR-mutated adenocarcinoma of the lung
LUX-Lung 7: Phase 2b trial of afatinib versus gefitinib for EGFR-mutated adenocarcinoma of the lung